Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group. Todisco E, et al. Among authors: roncoroni e. Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692409 Free article.
Improving survival trends in primary myelofibrosis: an international study.
Cervantes F, Dupriez B, Passamonti F, Vannucchi AM, Morra E, Reilly JT, Demory JL, Rumi E, Guglielmelli P, Roncoroni E, Tefferi A, Pereira A. Cervantes F, et al. Among authors: roncoroni e. J Clin Oncol. 2012 Aug 20;30(24):2981-7. doi: 10.1200/JCO.2012.42.0240. Epub 2012 Jul 23. J Clin Oncol. 2012. PMID: 22826273
Impact of Covid-19 on the treatment of acute myeloid leukemia.
Ferrara F, Zappasodi P, Roncoroni E, Borlenghi E, Rossi G. Ferrara F, et al. Among authors: roncoroni e. Leukemia. 2020 Aug;34(8):2254-2256. doi: 10.1038/s41375-020-0925-7. Epub 2020 Jun 19. Leukemia. 2020. PMID: 32561842 Free PMC article. No abstract available.
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.
Malfona F, Tanasi I, Piccini M, Papayannidis C, Federico V, Mancini V, Roncoroni E, Todisco E, Bianchi S, Ciotti G, Chiusolo P, Gentile M, Gianfelici V, Giglio F, Malagola M, Mulé A, Saraceni F, Vetro C, Zallio F, Cappelli LV, Pizzolo G, Foà R, Bonifacio M, Chiaretti S. Malfona F, et al. Among authors: roncoroni e. Haematologica. 2024 Mar 1;109(3):988-993. doi: 10.3324/haematol.2023.283684. Haematologica. 2024. PMID: 37794811 Free PMC article. No abstract available.
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Papayannidis C, Petracci E, Zappasodi P, Fracchiolla N, Ciceri F, Sartor C, Roncoroni E, Di Raimondo F, Mattei D, Giannini MB, Lanza F, Gottardi M, Del Principe MI, Borlenghi E, Fumagalli M, Vallisa D, Sica S, Di Renzo N, Fabbiano F, Todisco E, de Fabritiis P, Luppi M, Passamonti F, Corradini P, Petruzziello F, Pane F, Ferrara F, Mambelli G, Volpi R, Frabetti F, Zingaretti C, Marconi G, Martinelli G. Papayannidis C, et al. Among authors: roncoroni e. Cancer. 2025 Apr 1;131(7):e35820. doi: 10.1002/cncr.35820. Cancer. 2025. PMID: 40120068 Free PMC article.
Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage.
Merati G, Rossi M, Gallì A, Roncoroni E, Zibellini S, Rizzo E, Pietra D, Picone C, Rocca B, Cabrera CPT, Gelli E, Santacroce E, Arcaini L, Zappasodi P. Merati G, et al. Among authors: roncoroni e. Front Oncol. 2021 Aug 31;11:726637. doi: 10.3389/fonc.2021.726637. eCollection 2021. Front Oncol. 2021. PMID: 34540694 Free PMC article.
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.
Rossi M, Nizzoli ME, Gallì A, Roncoroni E, Zibellini S, Merati G, Rizzo E, Rocca B, Pietra D, Picone C, Brociner M, Tobar Cabrera CP, Gelli E, Santacroce E, Arcaini L, Zappasodi P. Rossi M, et al. Among authors: roncoroni e. Am J Hematol. 2022 Apr;97(4):E135-E138. doi: 10.1002/ajh.26469. Epub 2022 Jan 24. Am J Hematol. 2022. PMID: 35041232 Free article. No abstract available.
Unlocking Sanctuary Sites: The Efficacy of Brexucabtagene Autoleucel in Ocular B-ALL Relapse.
Calabretta L, Zappasodi P, Di Biase C, Picone C, Roncoroni E, Rossi M, Bianchessi A, Defrancesco I, Zerbi C, Ferrari B, Consensi E, Martini G, Tobar Cabrera CP, Battista C, Mazzacane A, Romano F, Losi G, Taurino A, Arcaini L, Polverelli N. Calabretta L, et al. Among authors: roncoroni e. Am J Hematol. 2025 Mar;100(3):483-487. doi: 10.1002/ajh.27572. Epub 2024 Dec 24. Am J Hematol. 2025. PMID: 39718764 No abstract available.
24 results